Accelerant agrees to be acquired by Thoma Bravo for $20.25 a share in cash
ARX•Closing targeted for first half of 2027
The companies said closing is targeted for the first half of 2027, subject to a shareholder vote and required insurance regulatory approvals.
Altamont affiliates controlling about 82% of voting rights agreed to support the transaction, and Thoma Bravo provided an equity commitment. Shares are expected to be delisted from the NYSE on completion, and Altamont and the founders plan to retain equity alongside Thoma Bravo.
Thoma Bravo to acquire Accelerant in all-cash deal
Thoma Bravo agreed to acquire Accelerant in an all-cash deal valuing the business at more than $4 billion.
Class A and Class B stockholders will receive $20.25 per share, a 49% premium to the Aug. 12, 2026 close.
